脊髓刺激市场规模、份额和成长分析（按适应症、产品、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，脊髓刺激 (SCS) 市场规模将达到 35 亿美元，到 2025 年将成长至 37.6 亿美元，到 2033 年将成长至 67.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.58%。

脊髓刺激（SCS）是一种神经调控设备，其透过传递电讯号阻断疼痛感知来缓解慢性疼痛的能力正日益受到关注。这种治疗方法在治疗脊椎相关疾病引起的疼痛以及背部、手臂和腿部的不适方面尤其有效，尤其适用于对传统治疗方法无效的患者。推动市场成长的关键因素包括技术进步、SCS手术相关法规的製定以及微创技术的日益普及。由于久坐不动的生活方式导致慢性疼痛盛行率不断上升，SCS市场正在经历显着扩张，为其在医疗保健领域的持续成长和进一步发展奠定了基础。

脊髓刺激市场驱动因素

随着製造商加强研发力度，致力于开发更紧凑的脊髓刺激设备，脊髓刺激设备市场正在蓬勃发展。例如，Stimwave LCC公司生产的Freedom SCS系统比目前市面上的植入式脉衝产生器（IPG）小约5%。这种小型化趋势不仅提高了患者的舒适度，也促进了脉衝发生技术的进步。这些创新在推动市场需求方面发挥关键作用，为改善治疗效果提供了契机，并为寻求缓解慢性疼痛的患者创造了更有利的环境。

限制脊髓刺激市场发展的因素

脊髓刺激市场面临植入费用高昂的严峻挑战，费用从21,000美元到58,000美元不等。这些费用因患者的医疗保险计划以及是否需要自付费用而有所不同。此外，持续的维护费用，例如硬体费用、医疗专业人员费用、脉衝发生器更换费用和住院费用，也加重了患者的经济负担。初始费用和持续维护费用的迭加显着限制了市场成长，总成本可能成为许多潜在患者的阻碍因素。

脊髓刺激市场趋势

脊髓刺激市场正经历显着成长，这主要得益于各国政府加强减少鸦片类药物成瘾。随着全球医疗系统转向替代性疼痛管理方案，脊髓刺激设备作为一种有效的非鸦片类疗法正日益受到关注。众多公司提交的创新解决方案申请正在寻求快速核准，以期取代阿片类药物用于疼痛管理，这充分证明了此类设备日益增长的市场接受度。此外，Medtronic、雅培和波士顿医疗设备，以满足市场对更安全、无成瘾性镇痛方案日益增长的需求，进一步推动了这一市场转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球脊髓刺激市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 背部手术失败综合症
• 复杂性局部疼痛症候群
• 椎间盘退化性疾病
• 其他的

全球脊髓刺激市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 可充电装置
• 不可充电设备

全球脊髓刺激市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 其他的

全球脊髓刺激市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• Nevro Corp.（USA）
• Stimwave Technologies, Inc.（USA）
• Saluda Medical Pty Ltd.（Australia）
• Synapse Biomedical Inc.（USA）
• Cirtec Medical（USA）
• Nalu Medical, Inc.（USA）
• Beijing PINS Medical Co., Ltd.（China）
• Gimer Medical（China）
• BIOTRONIK SE & Co. KG（Germany）
• St. Jude Medical, Inc.（acquired by Abbott）（USA）
• NeuroSigma, Inc.（USA）
• Greatbatch, Inc.（USA）
• Curonix LLC（USA）
• Teliatry, Inc.（USA）
• Spinal Modulation（USA）
• NevroSpin（USA）
• Axonics Modulation Technologies, Inc.（USA）

结论与建议

Spinal Cord Stimulation Market size was valued at USD 3.5 Billion in 2024 and is poised to grow from USD 3.76 Billion in 2025 to USD 6.75 Billion by 2033, growing at a CAGR of 7.58% during the forecast period (2026-2033).

The demand for spinal cord stimulation (SCS), a neuromodulation device designed to alleviate chronic pain by emitting electrical signals to block pain perception, is on the rise. This therapy is particularly effective for managing pain associated with spinal issues, as well as discomfort in the back, arms, and legs, especially in patients unresponsive to traditional treatments. Key factors driving market growth include advancements in technology, the establishment of regulations governing SCS procedures, and the increasing acceptance of minimally invasive techniques. As sedentary lifestyles contribute to a higher prevalence of chronic pain, the SCS market is experiencing significant expansion, positioning it for continued growth and additional opportunities in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Spinal Cord Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Spinal Cord Stimulation Market Segments Analysis

Global Spinal Cord Stimulation Market is segmented by indication, product, end user and region. Based on indication, the market is segmented into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. Based on product, the market is segmented into rechargeable devices and non-rechargeable devices. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Spinal Cord Stimulation Market

The spinal cord stimulation market is experiencing growth as manufacturers ramp up their research initiatives to develop more compact spinal cord stimulators. For example, the Freedom SCS system produced by Stimwave LCC demonstrates a reduction in size, being approximately 5% smaller than current Implantable Pulse Generators (IPG) available. This trend towards smaller devices not only enhances patient comfort but also facilitates advancements in impulse generation technology. Such innovations play a significant role in driving demand within the market, presenting opportunities for improved therapy effectiveness and fostering a more favorable environment for patients seeking relief from chronic pain.

Restraints in the Spinal Cord Stimulation Market

The spinal cord stimulation market faces significant challenges due to the high costs associated with implantations, which can range from US$ 21,000 to US$ 58,000. These expenses vary based on the type of health insurance coverage the patient possesses or if they are paying out-of-pocket. Furthermore, ongoing maintenance costs, including hardware expenses, healthcare professionals' fees, pulse generator replacements, and hospitalization charges, add to the financial burden. This combination of initial and recurring costs presents a major restraint on market growth, as many potential patients may find the overall expenditure prohibitive.

Market Trends of the Spinal Cord Stimulation Market

The Spinal Cord Stimulation market is witnessing a significant upward trend driven by heightened government initiatives aimed at reducing opioid dependence. As healthcare systems globally pivot towards alternative pain management solutions, spinal cord stimulation devices are gaining traction as effective non-opioid therapies. The growing acceptance of these devices is evidenced by numerous submissions from companies seeking expedited approvals for innovative solutions to replace opioids in pain management. This market shift is further supported by established medical device companies, including Medtronic, Abbott, and Boston Scientific, which are actively engaging in research and development to capitalize on the increasing demand for safer, non-addictive pain relief options.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Spinal Cord Stimulation Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

Global Spinal Cord Stimulation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Rechargeable Devices
• Non-Rechargeable Devices

Global Spinal Cord Stimulation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Global Spinal Cord Stimulation Market Size & CAGR (2026-2033)

• North America (Indication, Product, End User)
  • US
  • Canada
• Europe (Indication, Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cirtec Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nalu Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing PINS Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gimer Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (acquired by Abbott) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greatbatch, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curonix LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teliatry, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spinal Modulation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NevroSpin (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations